Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 0 | 14,969 |
| Gross Profit | N/A | N/A | N/A | N/A | 14,969 |
| Operating Expenses | 15,066 | 23,324 | 20,600 | 23,390 | 24,349 |
| Operating Income | -15,066 | -23,324 | -20,600 | -23,390 | -9,380 |
| Interest Expense | 13 | 12 | 13 | 12 | 17 |
| Other Income | 437 | 2,185 | 933 | 2,814 | 1,265 |
| Pre-tax Income | -14,642 | -21,151 | -19,680 | -20,588 | -8,132 |
| Income Tax | -71 | -25 | -22 | 3 | -3 |
| Net Income Continuous | -14,571 | -21,126 | -19,658 | -20,591 | -8,129 |
| Minority Interests | -5 | -2 | -10 | -51 | -15 |
| Net Income | $-14,566 | $-21,124 | $-19,648 | $-20,540 | $-8,114 |
| EPS Basic Total Ops | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 |
| EPS Basic Continuous Ops | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 |
| EPS Diluted Total Ops | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 |
| EPS Diluted Continuous Ops | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 |
| EBITDA(a) | $-14,165 | $-21,323 | $-18,566 | $-21,962 | $-7,905 |